In accordance with our data, in a recent manuscript Pascut et al. detected the presence of APE1 in the serum of HCC patients, suggesting this parameter as a possible biomarker for tracking cancer progression [58]. The gene discussed is APEX1; the disease is hepatocellular carcinoma.